Incepta Pharma introduces anti-diabetic medication ‘Orsema’
Incepta Pharmaceuticals Limited on Sunday (14 November) launched an anti-diabetic medication named "Orsema".
The injectable semaglutide medicine has been introduced in Bangladesh under the theme "Ensuring universal diabetes treatment" – commemorating this year's "World Diabetes Day", said a press release.
According to the press release, a weekly dose of "Orsema" will manage blood glucose levels among diabetic patients.
Keep updated, follow The Business Standard's Google news channel
The pre-filled syringe will be available in the market in two doses— 0.25mg priced at Tk350 and 0.50mg priced at Tk600.
